Tagged with Digitalization

ITTM’s innovative co-founder Dr. Andreas Kremer reveals the steps his start-up is currently undertaking to restructure the world of BioIT and the presentation of medical information. Why did you personally decide a year and half ago that ITTM was going to be your next adventure, and what were your first…

Singapore As a bio-informatics connoisseur with extensive experience in the pharmaceutical and clinical research field, Human Longevity’s Chief Information Officer, Yaron Turpaz, shares his insights on the company concept, the value proposition of big data in healthcare, as well as the overarching vision for the company’s bright global future. In a…

Ireland Colin Edwards, CEO of Merlin Consulting, a consulting firm providing services to the pharma, life sciences and digital health sectors in Ireland, discusses his reasons for leaving Boehringer Ingelheim to set up the company, his thoughts on the digital health landscape in Ireland, and the challenges that he foresees. We…

Slovakia Novartis Slovakia’s Marianthi Psaha discusses the upcoming shift in Slovakia’s healthcare landscape, the importance of a healthy dialogue between the public and private sectors, and the responsibility of the pharma industry to continuously strive for the highest standards of compliance, integrity and performance. You have been Country President for Slovakia…

Singapore Motivated by the transformative role of big data in healthcare, founder and CEO of Vishuo Biomedical, Dongliang Guo discusses the inspiration behind the company, the successful path to commercialization, as well as leveraging Singapore’s brand in the biomedical landscape. What was the inspiration for founding Vishuo Biomedical? What was the vision…

Switzerland Daniel Küng, CEO of Switzerland Global Enterprise (S-GE), the Swiss export promotion agency, also responsible for promoting Switzerland as a business location, reveals how the increase in the value of the Swiss Franc has brought Swiss companies to become more innovative when it comes to selling their products abroad; how…

Switzerland Dr. Othmar Pfannes, founder and CEO of Genedata, a bioinformatics company headquartered in Switzerland delivering enterprise software, data analysis consulting, and business-process analysis services to the life sciences community, reveals some insights into Genedata’s business strategy and how ultimately their mission is to contribute to reducing the costs of drug…

Novartis Dr Ann Aerts, head of the Novartis Foundation, discusses the role the Novartis Foundation plays within low and middle- income countries across the world and how integrating digital health solutions can strengthen health systems and contribute to global health.   We at the Novartis Foundation can leverage the expertise of…

Healthcare Noel Lantin, President of Medicomm Pacific, discusses the company’s evolution from providing medical publishing information exclusively to healthcare professionals to now patients, pharmaceutical companies and others across the value chain. He also discusses the company’s innovative website, as well as future mobile application plans, and how they are tools to…

Novartis Novartis Czech Republic’s Heidrun Irschik explains the potentially game-changing ramifications of Big Data on the Czech pharmaceutical and healthcare industries.   The opportunities offered by big data are present and we need to tap into this immense potential Heidrun Irschik, Novartis Big data: a technological phenomenon with potential commensurate to…

Healthcare Orange Healthcare CEO Elie Lobel discusses the importance of digitalization to the healthcare industry, major challenges, and the tremendous work that has already been done in the e-health regulatory field both in France and internationally. Could you give us a brief introduction to Orange Healthcare? What are the milestones and achievements…

Pharma Digitalization, a hot topic throughout the healthcare and life sciences industry, is having a major effect in Italy through more personalized home care for patients, allowing the government to cut costs, and enabling greater public access to innovative medical technologies. Telemedicine, a key differentiator in tender processes, is not yet used…